This is a Phase 1 study to determine the safety, tolerability, pharmacokinetics,pharmacodynamics, and preliminary efficacy of PRT7732 in patients with select advanced ormetastatic solid tumors with a SMARCA4 mutation.
This is a Phase 1 study to determine the safety, tolerability, pharmacokinetics,pharmacodynamics, and preliminary efficacy of PRT7732 in patients with select advanced ormetastatic solid tumors with a SMARCA4 mutation.